Hepatitis C treatment: current and future perspectives (Q34147323)

31 July 2017

10 references

23 March 2019

21 March 2019

22 June 2019

1 October 2019

7 November 2019

16 November 2019

20 November 2019

1 July 2020

27 October 2020

25 October 2022

Hepatitis C treatment: current and future perspectives (English)

1 reference

31 July 2017

9 references

23 March 2019

21 March 2019

22 June 2019

1 October 2019

7 November 2019

16 November 2019

20 November 2019

1 July 2020

27 October 2020

1 reference

1 October 2019

1 reference

7 November 2019

macromolecular substance

1 reference

16 November 2019

1 reference

20 November 2019

1 reference

27 October 2020

Zareen Fatima

10

1 reference

ORCID Public Data File 2021

Muhammad Idrees

object named as

Muhammad Idrees

3

1 reference

ORCID Public Data File 2021

Liaqat Ali

12

object named as

Liaqat Ali

1 reference

31 July 2017

5

Sadia Butt

1 reference

31 July 2017

Saira Munir

1

1 reference

31 July 2017

Sana Saleem

2

1 reference

31 July 2017

Aaliyah Tariq

4

1 reference

31 July 2017

Bisma Rauff

6

1 reference

31 July 2017

Abrar Hussain

7

1 reference

31 July 2017

Sadaf Badar

8

1 reference

31 July 2017

Mahrukh Naudhani

9

1 reference

31 July 2017

Muhmmad Ali

11

1 reference

31 July 2017

Madiha Akram

13

1 reference

31 July 2017

Mahwish Aftab

14

1 reference

31 July 2017

Bushra Khubaib

15

1 reference

31 July 2017

Zunaira Awan

16

1 reference

31 July 2017

language of work or name

1 reference

1 November 2010

11 references

31 July 2017

23 March 2019

21 March 2019

22 June 2019

1 October 2019

7 November 2019

16 November 2019

20 November 2019

1 July 2020

27 October 2020

25 October 2022

11 references

31 July 2017

23 March 2019

21 March 2019

22 June 2019

1 October 2019

7 November 2019

16 November 2019

20 November 2019

1 July 2020

27 October 2020

25 October 2022

7

1 reference

31 July 2017

page(s)

296

1 reference

Creative Commons Attribution 2.0 Generic

31 July 2017

copyright license

10 references

23 March 2019

21 March 2019

22 June 2019

1 October 2019

7 November 2019

16 November 2019

20 November 2019

1 July 2020

27 October 2020

on focus list of Wikimedia project

25 October 2022

copyright status

copyrighted

0 references

ScienceSource

0 references

cites work

A novel small molecule inhibitor of hepatitis C virus entry

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2984595

Hepatitis C: viral and host factors associated with non-response to pegylated interferon plus ribavirin.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2984595

Social networks shape the transmission dynamics of hepatitis C virus

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2984595

Review article: specifically targeted anti-viral therapy for hepatitis C - a new era in therapy

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2984595

Oyster mushroom laccase inhibits hepatitis C virus entry into peripheral blood cells and hepatoma cells.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2984595

Proanthocyanidin from Blueberry Leaves Suppresses Expression of Subgenomic Hepatitis C Virus RNA

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2984595

A study of best positive predictors for sustained virologic response to interferon alpha plus ribavirin therapy in naive chronic hepatitis C patients

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2984595

Treatment and vaccination for hepatitis C: present and future.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2984595

Frequency distribution of hepatitis C virus genotypes in different geographical regions of Pakistan and their possible routes of transmission

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2984595

Sustained virological response based on rapid virological response in genotype-3 chronic hepatitis C treated with standard interferon in the Pakistani population

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2984595

Epidemiology of hepatitis C virus infection in Pakistan

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2984595

Management of chronic hepatitis C: consensus guidelines

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2984595

Epidemiology of hepatitis C virus infection

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2984595

Virological response and safety outcomes in therapy-nai ve patients treated for chronic hepatitis C with taribavirin or ribavirin in combination with pegylated interferon alfa-2a: a randomized, phase 2 study

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2984595

Viral hepatitis in HIV infection

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2984595

In vitro replication models for the hepatitis C virus

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2984595

Hepatitis B and C virus in West-Central Turkey: seroprevalence in healthy individuals admitted to a university hospital for routine health checks

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2984595

Mechanisms of liver injury. III. Oxidative stress in the pathogenesis of hepatitis C virus

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2984595

Hepatitis C virus infection: the new global epidemic

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2984595

An in vitro model of hepatitis C virion production

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2984595

Hepatitis C virus core protein down-regulates transcription of interferon-induced antiviral genes.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2984595

PSG consensus statement on management of hepatitis C virus infection--2003.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2984595

Spectrum of hepatocellular carcinoma at Shifa International Hospital, Islamabad.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2984595

Interference of hepatitis C virus RNA replication by short interfering RNAs

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2984595

Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2984595

Clinical course of hepatitis C virus during the first decade of infection: cohort study

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2984595

The immunopathogenesis of hepatitis C virus infection

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2984595

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2984595

Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferon-alpha therapy

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2984595

Hepatitis C virus RNA in saliva and breastmilk of hepatitis C carrier mothers

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2984595

Hepatitis C virus serotype II responds more favorably to interferon-alpha therapy

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2984595

Diagnosis of occult hepatitis C without the need for a liver biopsy

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2984595

Activity of compounds from Chinese herbal medicine Rhodiola kirilowii (Regel) Maxim against HCV NS3 serine protease

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2984595

The hepatitis C virus NS3/4A protease complex interferes with pathways of the innate immune response

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2984595

Evolutionary dynamics of hepatitis C virus envelope genes during chronic infection.

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2984595

Frequency of hepatitis "C" in Buner, NWFP.

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2984595

General seroprevalence of hepatitis C and hepatitis B virus infections in population

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2984595

Randomised trial of interferon alpha2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus. International Hepatitis Interventional Therapy Group (I

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2984595

Hepatitis C virus in Zimbabwe.

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2984595

Hepatitis C virus genotypes in the United States: epidemiology, pathogenicity, and response to interferon therapy. Collaborative Study Group

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2984595

Transmission of hepatitis C virus from mothers to infants. The Vertical Transmission of Hepatitis C Virus Collaborative Study Group

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2984595

Coinfection with hepatitis B and C or B, C and delta viruses results in severe chronic liver disease and responds poorly to interferon-alpha treatment.

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2984595

Natural history of hepatitis C

28 October 2018

1 reference

12 December 2020

[Diagnostic strategies in Hepatitis C virus infection]

1 reference

12 December 2020

National Institutes of Health Consensus Development Conference Statement: Management of hepatitis C 2002 (June 10-12, 2002)

1 reference

12 December 2020

Dentistry as a possible route of hepatitis C transmission in Pakistan

1 reference

12 December 2020

Hepatitis C in hospital employees with needlestick injuries

1 reference

12 December 2020

Lack of transmission of hepatitis C in household contacts of children with homozygous beta-thalassaemia

1 reference

12 December 2020

New therapies for hepatitis C virus infection

1 reference

12 December 2020

High antibody level: an accurate serologic marker of viremia in asymptomatic people with hepatitis C infection

1 reference

12 December 2020

Identifiers

DOI

10.1186/1743-422X-7-296

1 reference

Dimensions Publication ID

31 July 2017

0 references

1 reference

31 July 2017

1 reference